Nuclear receptors, mitochondria and lipid metabolism

Mitochondrion

Volumn 8, Issue 4, 2008, Pages 329-337

  Alaynick, William A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Estrogen related receptor; Lipid metabolism; Liver X receptor; Mitochondria; Peroxisome proliferator associated receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; GLUCOCORTICOID; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROGESTERONE; RETINOID X RECEPTOR; RETINOL; STEROID RECEPTOR; TESTOSTERONE; THYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D;

DIABETES MELLITUS; DYSLIPIDEMIA; HORMONE ACTION; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC REGULATION; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; LIPID METABOLISM; METABOLIC SYNDROME X; MITOCHONDRIA; OBESITY; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS;

EID: 49649084735     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2008.02.001     Document Type: Review

References (111)

1. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., Jonker J.W., Giles W., Naviaux R.K., Giguere V., and Evans R.M. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 6 1 (2007) 13-24
2. Alberti S., Schuster G., Parini P., Feltkamp D., Diczfalusy U., Rudling M., Angelin B., Bjorkhem I., Pettersson S., and Gustafsson J.A. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J. Clin. Invest. 107 5 (2001) 565-573
3. Allen T., Zhang F., Moodie S.A., Clemens L.E., Smith A., Gregoire F., Bell A., Muscat G.E., and Gustafson T.A. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity. Diabetes 55 9 (2006) 2523-2533
4. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., Ahmad F., Matsui T., Chin S., Wu P.H., Rybkin II, Shelton J.M., Manieri M., Cinti S., Schoen F.J., Bassel-Duby R., Rosenzweig A., Ingwall J.S., and Spiegelman B.M. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 1 4 (2005) 259-271
5. Arany Z., Lebrasseur N., Morris C., Smith E., Yang W., Ma Y., Chin S., and Spiegelman B.M. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5 1 (2007) 35-46
6. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 4 (1999) 585-595
7. Barger P.M., and Kelly D.P. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc. Med. 10 6 (2000) 238-245
8. Barish G.D., Downes M., Alaynick W.A., Yu R.T., Ocampo C.B., Bookout A.L., Mangelsdorf D.J., and Evans R.M. A nuclear receptor atlas: macrophage activation. Mol. Endocrinol. 19 10 (2005) 2466-2477
9. Barish G.D., Narkar V.A., and Evans R.M. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116 3 (2006) 590-597
10. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53 (2002) 409-435
11. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., and Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 4 (2006) 789-799
12. Carrier J.C., Deblois G., Champigny C., Levy E., and Giguere V. Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem. 279 50 (2004) 52052-52058
13. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 5548 (2001) 1866-1870
14. Chen H., Tini M., and Evans R.M. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 13 2 (2001) 218-224
15. Chen J., and Nathans J. Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis. Dev. Cell 13 3 (2007) 325-337
16. Chen J.Q., Yager J.D., and Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim. Biophys. Acta 1746 1 (2005) 1-17
17. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., Evans R.M., Schneider M.D., Brako F.A., Xiao Y., Chen Y.E., and Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10 11 (2004) 1245-1250
18. Claudel T., Leibowitz M.D., Fievet C., Tailleux A., Wagner B., Repa J.J., Torpier G., Lobaccaro J.M., Paterniti J.R., Mangelsdorf D.J., Heyman R.A., and Auwerx J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA 98 5 (2001) 2610-2615
19. Coward P., Lee D., Hull M.V., and Lehmann J.M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc. Natl. Acad. Sci. USA 98 15 (2001) 8880-8884
20. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M.D., Colombel J.F., and Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 193 7 (2001) 827-838
21. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 5 (1999) 649-688
22. Dressel U., Allen T.L., Pippal J.B., Rohde P.R., Lau P., and Muscat G.E. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol. Endocrinol. 17 12 (2003) 2477-2493
23. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., and Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 5 5 (2007) 345-356
24. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 9468 (2005) 1415-1428
25. Escriva H., Bertrand S., and Laudet V. The evolution of the nuclear receptor superfamily. Essays Biochem. 40 (2004) 11-26
26. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 4854 (1988) 889-895
27. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 10 4 (2004) 355-361
28. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl. 1 (2004) S43-S50
29. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 14 (2002) 1723-1727
30. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 7 (2005) 1769-1778
31. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 94 9 (1997) 4312-4317
32. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 5 (1995) 803-812
33. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 42 (2001) 38378-38387
34. Giguere V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 6151 (1988) 91-94
35. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 2 (2000) 121-141
36. Greschik H., Flaig R., Renaud J.P., and Moras D. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J. Biol. Chem. 279 32 (2004) 33639-33646
37. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., and Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 2 (2002) 303-313
38. Grundy S.M. Point: the metabolic syndrome still lives. Clin. Chem. 51 8 (2005) 1352-1354
39. Haffner C.D., Lenhard J.M., Miller A.B., McDougald D.L., Dwornik K., Ittoop O.R., Gampe Jr. R.T., Xu H.E., Blanchard S., Montana V.G., Consler T.G., Bledsoe R.K., Ayscue A., and Croom D. Structure-based design of potent retinoid X receptor alpha agonists. J. Med. Chem. 47 8 (2004) 2010-2029
40. Handschin C., Chin S., Li P., Liu F., Maratos-Flier E., Lebrasseur N.K., Yan Z., and Spiegelman B.M. Skeletal muscle fiber-type switching, exercise intolerance and myopathy in PGC-1alpha muscle-specific knockout animals. J. Biol. Chem. (2007)
41. Harris P.K., and Kletzien R.F. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol. Pharmacol. 45 3 (1994) 439-445
42. He W., Barak Y., Hevener A., Olson P., Liao D., Le J., Nelson M., Ong E., Olefsky J.M., and Evans R.M. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100 26 (2003) 15712-15717
43. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., and Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 6852 (2001) 179-183
44. Hevener A.L., He W., Barak Y., Le J., Bandyopadhyay G., Olson P., Wilkes J., Evans R.M., and Olefsky J. Muscle-specific Pparg deletion causes insulin resistance. Nat. Med. 9 12 (2003) 1491-1497
45. Hong H., Yang L., and Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274 32 (1999) 22618-22626
46. Horowitz J.F., Leone T.C., Feng W., Kelly D.P., and Klein S. Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. Am. J. Physiol. Endocrinol. Metab. 279 2 (2000) E348-E355
47. Huss J.M., Imahashi K., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., Giguere V., Murphy E., and Kelly D.P. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 6 1 (2007) 25-37
48. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 6602 (1996) 728-731
49. Jucker B.M., Doe C.P., Schnackenberg C.G., Olzinski A.R., Maniscalco K., Williams C., Hu T.C., Lenhard S.C., Costell M., Bernard R., Sarov-Blat L., Steplewski K., and Willette R.N. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure. J. Cardiovasc. Pharmacol. 50 1 (2007) 25-34
50. Kamei Y., Ohizumi H., Fujitani Y., Nemoto T., Tanaka T., Takahashi N., Kawada T., Miyoshi M., Ezaki O., and Kakizuka A. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl. Acad. Sci. USA 100 21 (2003) 12378-12383
51. Kelly D.P., and Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18 4 (2004) 357-368
52. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 6 (2004) 2548-2556
53. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 11 (1999) 1489-1498
54. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., and Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 5 (1995) 813-819
55. Kressler D., Schreiber S.N., Knutti D., and Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J. Biol. Chem. 277 16 (2002) 13918-13925
56. Lago R.M., Singh P.P., and Nesto R.W. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370 9593 (2007) 1129-1136
57. Lalloyer F., Fievet C., Lestavel S., Torpier G., van der Veen J., Touche V., Bultel S., Yous S., Kuipers F., Paumelle R., Fruchart J.C., Staels B., and Tailleux A. The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 26 12 (2006) 2731-2737
58. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., and Curtiss L.K. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302 5644 (2003) 453-457
59. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., and Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 7 (2000) 847-856
60. Lehman J.J., and Kelly D.P. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 29 4 (2002) 339-345
61. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 6 (1997) 3137-3140
62. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 22 (1995) 12953-12956
63. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 13 (1999) 7473-7478
64. Li X., Hansen P.A., Xi L., Chandraratna R.A., and Burant C.F. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. J. Biol. Chem. 280 46 (2005) 38317-38327
65. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., and Spiegelman B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418 6899 (2002) 797-801
66. Liu S., Ogilvie K.M., Klausing K., Lawson M.A., Jolley D., Li D., Bilakovics J., Pascual B., Hein N., Urcan M., and Leibowitz M.D. Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology 143 8 (2002) 2880-2885
67. Luo J., Sladek R., Bader J.A., Matthyssen A., Rossant J., and Giguere V. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature 388 6644 (1997) 778-782
68. Luo J., Sladek R., Carrier J., Bader J.A., Richard D., and Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol. Cell. Biol. 23 22 (2003) 7947-7956
69. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 6 (1995) 835-839
70. Medina-Gomez G., Gray S.L., Yetukuri L., Shimomura K., Virtue S., Campbell M., Curtis R.K., Jimenez-Linan M., Blount M., Yeo G.S., Lopez M., Seppanen-Laakso T., Ashcroft F.M., Oresic M., and Vidal-Puig A. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3 4 (2007) e64
71. Mitsunaga K., Araki K., Mizusaki H., Morohashi K., Haruna K., Nakagata N., Giguere V., Yamamura K., and Abe K. Loss of PGC-specific expression of the orphan nuclear receptor ERR-beta results in reduction of germ cell number in mouse embryos. Mech. Dev. 121 3 (2004) 237-246
72. Mukherjee R., Davies P.J., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., Hamann L.G., Boehm M.F., Mondon C.E., Nadzan A.M., Paterniti Jr. J.R., and Heyman R.A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386 6623 (1997) 407-410
73. Muoio D.M., MacLean P.S., Lang D.B., Li S., Houmard J.A., Way J.M., Winegar D.A., Corton J.C., Dohm G.L., and Kraus W.E. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277 29 (2002) 26089-26097
74. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 6698 (1998) 137-143
75. Norris A.W., Chen L., Fisher S.J., Szanto I., Ristow M., Jozsi A.C., Hirshman M.F., Rosen E.D., Goodyear L.J., Gonzalez F.J., Spiegelman B.M., and Kahn C.R. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J. Clin. Invest. 112 4 (2003) 608-618
76. Ogawa S., Lozach J., Jepsen K., Sawka-Verhelle D., Perissi V., Sasik R., Rose D.W., Johnson R.S., Rosenfeld M.G., and Glass C.K. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl. Acad. Sci. USA 101 40 (2004) 14461-14466
77. Ogilvie K.M., Saladin R., Nagy T.R., Urcan M.S., Heyman R.A., and Leibowitz M.D. Activation of the retinoid X receptor suppresses appetite in the rat. Endocrinology 145 2 (2004) 565-573
78. Olshansky S.J., Passaro D.J., Hershow R.C., Layden J., Carnes B.A., Brody J., Hayflick L., Butler R.N., Allison D.B., and Ludwig D.S. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352 11 (2005) 1138-1145
79. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., and Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93 5 (1998) 693-704
80. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., and Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423 6939 (2003) 550-555
81. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 6 (1998) 829-839
82. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., and Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 4 (1998) 531-541
83. Repa J.J., and Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16 (2000) 459-481
84. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., and Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 100 7 (2003) 4012-4017
85. Rodriguez-Calvo R., Jove M., Coll T., Camins A., Sanchez R.M., Alegret M., Merlos M., Pallas M., Laguna J.C., and Vazquez-Carrera M. PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice. J. Gerontol. A Biol. Sci. Med. Sci. 61 8 (2006) 773-780
86. Rosen E.D., and Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16 (2000) 145-171
87. Rosen E.D., and Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276 41 (2001) 37731-37734
88. Roy D., Felty Q., Narayan S., and Jayakar P. Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy. Front. Biosci. 12 (2007) 154-173
89. Schilling M.M., Oeser J.K., Boustead J.N., Flemming B.P., and O'Brien R.M. Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection. Nature 443 7111 (2006) E10-E11
90. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., and Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. USA 102 7 (2005) 2340-2345
91. Schreiber S.N., Emter R., Hock M.B., Knutti D., Cardenas J., Podvinec M., Oakeley E.J., and Kralli A. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. USA 101 17 (2004) 6472-6477
92. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., and Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278 11 (2003) 9013-9018
93. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., and Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129 4 (2007) 723-733
94. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14 22 (2000) 2831-2838
95. Shulman A.I., and Mangelsdorf D.J. Retinoid X receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353 6 (2005) 604-615
96. Singh Ahuja H., Liu S., Crombie D.L., Boehm M., Leibowitz M.D., Heyman R.A., Depre C., Nagy L., Tontonoz P., and Davies P.J. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol. Pharmacol. 59 4 (2001) 765-773
97. Sonoda J., Mehl I.R., Chong L.W., Nofsinger R.R., and Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc. Natl. Acad. Sci. USA 104 12 (2007) 5223-5228
98. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., and Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127 2 (2006) 397-408
99. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R.X., Tachibana K., Watanabe Y., Uchiyama Y., Sumi K., Iguchi H., Ito S., Doi T., Hamakubo T., Naito M., Auwerx J., Yanagisawa M., Kodama T., and Sakai J. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100 26 (2003) 15924-15929
100. Tontonoz P., and Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 6 (2003) 985-993
101. Villena J.A., Hock M.B., Chang W.Y., Barcas J.E., Giguere V., and Kralli A. Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc. Natl. Acad. Sci. USA 104 4 (2007) 1418-1423
102. Wang Y.X., Lee C.H., Tiep S., Yu R.T., Ham J., Kang H., and Evans R.M. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113 2 (2003) 159-170
103. Wang Y.X., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., Ham J., Kang H., and Evans R.M. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2 10 (2004) e294
104. Weitzel J.M., Iwen K.A., and Seitz H.J. Regulation of mitochondrial biogenesis by thyroid hormone. Exp. Physiol. 88 1 (2003) 121-128
105. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., Beck K.D., Moore L.B., Kliewer S.A., and Lehmann J.M. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39 3 (1996) 665-668
106. Willson T.M., Lehmann J.M., and Kliewer S.A. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Ann. NY Acad. Sci. 804 (1996) 276-283
107. Willy P.J., Murray I.R., Qian J., Busch B.B., Stevens Jr. W.C., Martin R., Mohan R., Zhou S., Ordentlich P., Wei P., Sapp D.W., Horlick R.A., Heyman R.A., and Schulman I.G. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. USA 101 24 (2004) 8912-8917
108. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., and Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 1 (1999) 115-124
109. Xie W., Hong H., Yang N.N., Lin R.J., Simon C.M., Stallcup M.R., and Evans R.M. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 13 12 (1999) 2151-2162
110. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., Sternbach D.D., Lehmann J.M., Wisely G.B., Willson T.M., Kliewer S.A., and Milburn M.V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3 3 (1999) 397-403
111. Yoon J.C., Xu G., Deeney J.T., Yang S.N., Rhee J., Puigserver P., Levens A.R., Yang R., Zhang C.Y., Lowell B.B., Berggren P.O., Newgard C.B., Bonner-Weir S., Weir G., and Spiegelman B.M. Suppression of beta cell energy metabolism and insulin release by PGC-1alpha. Dev. Cell 5 1 (2003) 73-83